PET Clinical Trials

153 recruitingLast updated: June 18, 2026

There are 153 actively recruiting pet clinical trials across 37 countries. Studies span Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Shanghai, Shanghai Municipality, China, Wuhan, Hubei, China. Updated daily from ClinicalTrials.gov.


PET Trials at a Glance

153 actively recruiting trials for pet are listed on ClinicalTrialsFinder across 6 cities in 37 countries. The largest study group is Not Applicable with 75 trials, with the heaviest enrollment activity in Boston, Shanghai, and Wuhan. Lead sponsors running pet studies include The First Affiliated Hospital of Xiamen University, Zhongnan Hospital, and Peking Union Medical College Hospital.

Treatments under study

About PET Clinical Trials

Looking for clinical trials for PET? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new PET trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about PET clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 153 trials

Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation Combined With Bimanual Therapy for Upper Limb Stroke Rehabilitation

NeuromodulationRepetitive Transcranial Magnetic Stimulation (rTMS)Post-stroke Upper Limb Hemiparesis+1 more
Chang Gung Memorial Hospital54 enrolled1 locationNCT07054424
Recruiting
Phase 3

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

Primary myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals460 enrolled13 locationsNCT07357727
Recruiting
Phase 2

A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations

PET/CT ImagingPilot StudyHost Disease Manifestation
M.D. Anderson Cancer Center16 enrolled1 locationNCT07325253
Recruiting
Phase 2

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

Breast Cancer FemaleLobular Breast CarcinomaPET/MRI+2 more
Università Vita-Salute San Raffaele119 enrolled1 locationNCT05982496
Recruiting
Phase 2

Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis

Colorectal, CancerPeritoneal (Metastatic) CancerFAPI PET
Fudan University40 enrolled2 locationsNCT07079462
Recruiting
Not Applicable

Satiety Evaluation of Mature Okra Flour-incorporated Biscuit

Healthy Young AdultsAppetite regulation
Universiti Putra Malaysia30 enrolled1 locationNCT07631663
Recruiting
Not Applicable

Aconselha + Movimento: Protocol for Online Training on Physical Activity and Sedentary Behavior Counseling

ExerciseCounselingPrimary Health Care+3 more
Universidade Federal do Paraná3,306 enrolled3 locationsNCT07636291
Recruiting
Phase 1

Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation

Repetitive head impacts
Pravat Mandal30 enrolled1 locationNCT07050173
Recruiting
Not Applicable

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

Infertility (IVF Patients)Sperm DNA FragmentationOocyte Competence+2 more
Reproductive Medicine Associates of New Jersey100 enrolled1 locationNCT06629766
Recruiting
Not Applicable

A Robotic Mental Health Simulation Intervention to Enhance Professional Identity, Interpersonal Communication Competence, and Emotional Intelligence Among Saudi Nursing Students: A Quasi-Experimental Study

Mental Health SimulationProfessional IdentityInterpersonal Communication Competence
Alexandria University80 enrolled1 locationNCT07627646
Recruiting
Phase 2

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Prostate CancerRecurrent Prostate CancerPET Positive
National Cancer Institute (NCI)65 enrolled1 locationNCT06096870
Recruiting

New AI-based Technologies in Nuclear Medicine

Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Azienda USL Reggio Emilia - IRCCS1,500 enrolled1 locationNCT07174089
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Global Developmental Delay

Global developmental delayRepetitive Transcranial Magnetic Stimulation (rTMS)Developmental Delay Disorder+1 more
Xiangya Hospital of Central South University50 enrolled1 locationNCT07369960
Recruiting
Not Applicable

The Role of Estradiol and Progesterone on Appetite Regulation and Energy Balance

Energy BalancePhysiology - Regulation of Appetite and Food Intake
Wilfrid Laurier University60 enrolled1 locationNCT07620587
Recruiting
Not Applicable

PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy

PSMA PETProstate Cancer Screening
First Affiliated Hospital of Fujian Medical University230 enrolled1 locationNCT06923657
Recruiting
Not Applicable

The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.

Chronic stroke survivorsStrokeTranscranial Magnetic Stimulation+6 more
Duke University26 enrolled1 locationNCT06765642
Recruiting
Not Applicable

Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking

NeurofeedbackRepetitive Negative Thinking
Massachusetts General Hospital100 enrolled1 locationNCT07055217
Recruiting

A Tool of the Future for Strengthening Compassion in a Danish Hospital Setting.

BurnoutCompassion AbilityCompassion Competence+2 more
Herlev and Gentofte Hospital2,200 enrolled1 locationNCT07568977
Recruiting
Phase 2

Y-4 to Treat the Postherpetic Neuralgia

Postherpetic NeuralgiaPregabalinY-4
Neurodawn Pharmaceutical Co., Ltd.160 enrolled1 locationNCT07275762
Recruiting
Phase 1

A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+3 more
Ajax Therapeutics, Inc.76 enrolled21 locationsNCT06343805